R&D pipeline
Novo Nordisk, Lilly see insatiable demand for weight-loss drugs | Reuters
Novo Nordisk expects China to approve weight loss drug Wegovy this year | Reuters
Novo Nordisk foundation to place more grants outside Denmark | Reuters
Novo Nordisk raises full-year guidance again as US sales of Wegovy, Ozempic fly | Reuters
Novo Nordisk logo
NOVO NORDISK TAKES ON THE WEIGH OF THE WORLD
Meet Team Novo Nordisk | Pro Team | Development Team
Contact Novo Nordisk - our local offices
Novo Nordisk to invest $2.3bn to expand manufacturing facilities
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Novo Nordisk - Wikipedia
Novo Nordisk - Wikipedia
Novo Nordisk to Sell Discount Insulin After Criticism Over Price - Bloomberg
Novo Nordisk shares jump 8% on promising weight loss trial results; Eli Lilly dips
:max_bytes(150000):strip_icc()/GettyImages-1692436765-45ad725a7e7044629018f733a1de194c.jpg "Novo Nordisk Boosts Its Guidance on Demand for Its Weight-Loss Drugs, Again")
Novo Nordisk Boosts Its Guidance on Demand for Its Weight-Loss Drugs, Again
Novo Nordisk stock hits record on new weight loss drug trial
How high can Novo Nordisk shares go? | Euronews
Novo Nordisk Foundation - Wikipedia
Team Novo Nordisk and Novo Nordisk confirm three-year renewal of historic partnership
The Novo Nordisk Prize – Advances in medical science - Novo Nordisk Fonden
Novo Nordisk Kalundborg
Novo Nordisk completes acquisition of Dicerna Pharmaceuticals - Drug Delivery Business
